NCT04521686 2026-04-22Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT05283330 2026-03-20Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsOrano Med LLCPhase 1 Recruiting48 enrolled
NCT04478279 2026-02-09A Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsSapience TherapeuticsPhase 1/2 Active not recruiting125 enrolled